Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-12-356879
Filing Date
2012-08-15
Accepted
2012-08-15 10:37:56
Documents
13
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d365488d10k.htm 10-K 1490896
2 LIST OF SUBSIDIARIES OF THE REGISTRANT d365488dex211.htm EX-21.1 5690
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM d365488dex231.htm EX-23.1 4620
4 SECTION 302 CEO CERTIFICATION d365488dex311.htm EX-31.1 9167
5 SECTION 302 CFO CERTIFICATION d365488dex312.htm EX-31.2 9147
6 SECTION 906 CEO AND CFO CERTIFICATION d365488dex32.htm EX-32 3878
13 GRAPHIC g365488gra.jpg GRAPHIC 40220
  Complete submission text file 0001193125-12-356879.txt   9763455

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mygn-20120630.xml EX-101.INS 1600055
8 XBRL TAXONOMY EXTENSION SCHEMA mygn-20120630.xsd EX-101.SCH 86158
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mygn-20120630_cal.xml EX-101.CAL 119986
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mygn-20120630_def.xml EX-101.DEF 426459
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20120630_lab.xml EX-101.LAB 626420
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20120630_pre.xml EX-101.PRE 506863
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26642 | Film No.: 121035627
SIC: 2835 In Vitro & In Vivo Diagnostic Substances